RE:Treatment CostI think Alstiladrin is going to make $Zilch.. Per patient. The reason I think that is TLT and 1433 could beat them to market. Yes they are FDA approved but as CancerSlayer has mentioned. They still have a few hoops to jump through before they can start selling it. So I think 1433 could be somewhere closer to their lower price point per patient, so a higher cost per dose, yet still very copetitive since fewer doses, standalone, better CR %. Non-toxic.